Pharmaceuticals News and Research

RSS

New protocol for HIV prevention drug reduces the number of pills required

Health officials and AIDS advocates in San Francisco hope to expand the use of an effective HIV prevention drug with a new approach that requires fewer pills than the standard once-a-day regimen.

29 Jul 2019

Study analyzes the prevalence of antipsychotic use in youths with ADHD

Although fewer young people with ADHD are treated with antipsychotic drugs than suspected, many prescriptions for the drugs do not appear to be clinically warranted, according to a new study from psychiatry researchers at Columbia University Vagelos College of Physicians and Surgeons.

26 Jul 2019

GOP senators distance themselves from Grassley and Trump’s efforts to cut drug prices

The fight between policymakers intent on lowering prescription drug prices and the drugmakers who keep raising them intensified Thursday, as a slew of Republican senators threatened to side with manufacturers against legislation supported by their own committee chairman and president.

25 Jul 2019

KHN’s ‘What the Health?’: Cue the drug price debate

The Republican and Democratic leaders of the Senate Finance Committee this week unveiled a sweeping proposal that seeks to lower prescription drug prices for the Medicare and Medicaid programs.

25 Jul 2019

Summer setbacks: The long road to lower drug prices hits some potholes

When Washington returned from its winter holiday break in January, it seemed everyone was talking about lowering drug prices.

24 Jul 2019

New analysis quantifies how stimulant treatment reduces serious outcomes of ADHD

An analysis of three previous studies of children and young adults with attention-deficit hyperactivity disorder quantifies for the first time the extent to which stimulant treatment reduces the development of mood disorders, school problems, conduct disorders, substance use disorders and other problems.

23 Jul 2019

FDA grants approval for generic versions of Lyrica

On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, as an adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older, for the management of fibromyalgia, and for the management of neuropathic pain associated with spinal cord injury.

22 Jul 2019

New EU-funded project helping to develop safer, more effective medicines

Chiral pharmaceuticals are widely used in clinical treatments and agriculture. They include non-steroid anti-inflammatory drugs, Î²-blockers for reducing blood pressure, and herbicides and pesticides.

22 Jul 2019

Disruption of immune cell behavior may spur heart disease, heart failure

On an ice hockey team, the players all start off with identical uniforms, skates and a stick. But if you take one of them, add padding, a glove, and a mask; and switch the stick to one with a larger blade, then you get a goalie.

From Johns Hopkins Medicine 19 Jul 2019

Some pharmacists not adhering to therapeutic guidelines, QUT study finds

As the role of pharmacies in providing front-line public health services grows, a QUT study has raised concerns that some are not adhering to therapeutic guidelines when distributing pharmaceuticals.

19 Jul 2019

Some pharmacists fail to adhere to therapeutic guidelines, highlights study

As the role of pharmacies in providing front-line public health services grows, a QUT study has raised concerns that some are not adhering to therapeutic guidelines when distributing pharmaceuticals.

19 Jul 2019

KHN’s ‘What the Health?’: Biden doubles down on Obamacare

Former Vice President Joe Biden has said if he's elected president he would build on the Affordable Care Act rather than move to a whole new health care system, such as the "Medicare for All" plan supported by some of his primary opponents for the Democratic nomination.

19 Jul 2019

Common medications can masquerade as dementia in seniors

By all accounts the woman, in her late 60s, appeared to have severe dementia. She was largely incoherent. Her short-term memory was terrible. She couldn't focus on questions that medical professionals asked her.

18 Jul 2019

New research shows significant gaps in deployment of 'coverage with evidence development'

Value in Health, the official journal of ISPOR- the professional society for health economics and outcomes research, announced today the publication of new research from The Netherlands showing important gaps in the deployment of "coverage with evidence development," a type of pharmaceutical managed entry agreement that gives patients access to treatments while additional evidence is being collected.

15 Jul 2019